Dengue Envelope Protein as a Cytotoxic Factor Inducing Hemorrhage and Endothelial Cell Death in Mice
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910858 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Te-Sheng Lien und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien 970, Taiwan. Hauptthemen laut MEDLINE: Dengue Virus, Endothelial Cells, Viral Envelope Proteins, Apoptosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, Tzu-Chi Medical Foundation, National Science and Technology Council.
Abstract (Originalsprache)
Dengue virus (DENV) infection, prevalent in tropical and subtropical regions, can progress to dengue hemorrhagic fever (DHF), which increases mortality during secondary infections. DHF is characterized by endothelial damage and vascular leakage. Despite its severity, no specific antiviral treatments exist, and the viral factors responsible for endothelial damage remain unclear. This study examines the role of the DENV envelope protein domain III (EIII) in inducing endothelial apoptosis using a mouse model. Additionally, we aim to explore whether cell death-inducing pathways could serve as drug targets to ameliorate EIII-induced endothelial injury and hemorrhage. In vitro experiments using human endothelial HMEC-1 cells demonstrated that both recombinant EIII (rEIII) and DENV markedly induced caspase-3-mediated endothelial cell death, an effect that was attenuated by co-treatment with chondroitin sulfate B (CSB), N-acetyl cysteine (NAC), and the caspase-3 inhibitor z-DEVD-FMK. In vivo, sequential injections of rEIII and anti-platelet immunoglobulin in mice, designed to mimic the clinical phase of DHF with peak viremia followed by an increase in DENV-induced Ig, including autoantibodies, revealed that these dual treatments markedly triggered caspase-3-dependent apoptosis in vascular endothelial cells at hemorrhage sites. Treatments with z-DEVD-FMK effectively reduced DHF-like symptoms such as thrombocytopenia, hemorrhage, inflammation, hypercoagulation, and endothelial damage. Additionally, CSB and NAC alleviated hemorrhagic symptoms in the mice. These results suggest that targeting EIII, reactive oxygen species, and caspase-3-mediated apoptosis could offer potential therapeutic strategies for addressing EIII-induced hemorrhagic pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien 970, Taiwan.
- Division of General Surgery, Department of Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.
- Department of Laboratory Medicine and Biotechnology, College of Medicine, Tzu Chi University, Hualien 970, Taiwan.
ORCID-Profile: Der-Shan Sun, Wen-Sheng Wu, Hsin-Hou Chang
Förderung
- National Science and Technology Council, Taiwan
- Tzu-Chi Medical Foundation
- National Science and Technology Council
Zitieren
APA
Lien, T. S., Sun, D. S., Wu, W. S., & Chang, H. H. (2024). Dengue Envelope Protein as a Cytotoxic Factor Inducing Hemorrhage and Endothelial Cell Death in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910858
Vancouver
Lien TS, Sun DS, Wu WS, Chang HH. Dengue Envelope Protein as a Cytotoxic Factor Inducing Hemorrhage and Endothelial Cell Death in Mice. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910858
BibTeX
@article{Lien2024,
author = {Lien, Te-Sheng and Sun, Der-Shan and Wu, Wen-Sheng and Chang, Hsin-Hou},
title = {Dengue Envelope Protein as a Cytotoxic Factor Inducing Hemorrhage and Endothelial Cell Death in Mice},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910858}
}
EUVIMED